Medcom Tech (MED.MC) Stock Price
Medcom Tech Price
Over the last 16 years Medcom Tech grew revenue by 11.7% annually, reaching 22.41 M EUR. Earnings per share have grown at 15.7% per year over the last 13 years. For Medcom Tech, the net margin of -3.5% is up versus -35.0% a few years ago.
Medcom Tech stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Medcom Tech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Medcom Tech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Medcom Tech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Medcom Tech Price |
|---|
Medcom Tech Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Medcom Tech Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM EUR |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM EUR |
| EBITM EUR |
| EBIT MARGIN% |
| NET INCOMEM EUR |
| NET INCOME GROWTH% |
| DIVIDENDDIV.EUR |
| SHARESM |
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.00 | 6.00 | 10.00 | 12.00 | 14.00 | 16.00 | 18.00 | 20.00 | 25.00 | 27.00 | 28.00 | 24.00 | 22.00 | 18.00 | 20.00 | 22.00 |
| 33.33 | 50.00 | 66.67 | 20.00 | 16.67 | 14.29 | 12.50 | 11.11 | 25.00 | 8.00 | 3.70 | -14.29 | -8.33 | -18.18 | 11.11 | 10.00 |
| 75.00 | 66.67 | 60.00 | 58.33 | 71.43 | 62.50 | 61.11 | 60.00 | 64.00 | 59.26 | 57.14 | 54.17 | 68.18 | 61.11 | 55.00 | 63.64 |
| 3.00 | 4.00 | 6.00 | 7.00 | 10.00 | 10.00 | 11.00 | 12.00 | 16.00 | 16.00 | 16.00 | 13.00 | 15.00 | 11.00 | 11.00 | 14.00 |
| – | 1.00 | 2.00 | 2.00 | – | 1.00 | 1.00 | – | -1.00 | -1.00 | -2.00 | -8.00 | 8.00 | – | – | – |
| – | 16.67 | 20.00 | 16.67 | – | 6.25 | 5.56 | – | -4.00 | -3.70 | -7.14 | -33.33 | 36.36 | – | – | – |
| – | – | 1.00 | 1.00 | – | – | – | – | -1.00 | -2.00 | -2.00 | -8.00 | 4.00 | -1.00 | – | – |
| – | – | – | – | – | – | – | – | – | 100.00 | – | 300.00 | -150.00 | -125.00 | – | – |
| – | – | – | – | – | – | – | 0.05 | – | 0.03 | – | – | – | – | – | – |
| 6.42 | 6.42 | 6.42 | 9.01 | 9.00 | 10.10 | 10.10 | 10.10 | 10.10 | 10.10 | 10.98 | 10.98 | 12.98 | 12.94 | 12.92 | 12.92 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Medcom Tech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Medcom Tech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Medcom Tech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Medcom Tech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Medcom Tech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Medcom Tech stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Medcom Tech Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Medcom Tech business model & stock analysis
Medcom Tech SWOT Analysis
Strengths
Medcom Tech SA has a strong market presence and brand recognition in the healthcare industry. The company's advanced technological solutions and innovative products set it apart from competitors. Medcom Tech SA's strong research and development capabilities enable it to continuously improve its offerings. The company has a highly skilled and experienced workforce that contributes to its success.
Weaknesses
Medcom Tech SA faces challenges in terms of high production costs, which may impact its profitability. The company's heavy reliance on a limited number of suppliers could lead to supply chain disruptions. Medcom Tech SA's limited geographical presence may hinder its ability to expand into new markets. The company's dependence on a few key customers puts it at risk of revenue fluctuations.
Opportunities
Medcom Tech SA has the opportunity to enter emerging markets and tap into growing demand for healthcare technologies. The increasing adoption of digital health solutions presents an opportunity for the company to expand its product portfolio. Medcom Tech SA can leverage partnerships and collaborations to enhance its market reach and access new customers. The current trend towards remote healthcare services opens up opportunities for the company's telemedicine solutions.
Threats
Medcom Tech SA faces intense competition from both established players and new entrants in the healthcare technology market. Regulatory changes and compliance requirements pose a threat to the company's operations and product development. Economic downturns and uncertainty in the healthcare industry can impact Medcom Tech SA's revenue and customer demand. The rapid pace of technological advancements may render certain products obsolete, posing a threat to the company's offerings.
Medcom Tech Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Medcom Tech historical P/E ratio, EBIT multiple, and P/S ratio
Medcom Tech annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Medcom Tech's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Medcom Tech's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Medcom Tech's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Medcom Tech shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Medcom Tech Dividend History
4 years of dividend payments
Medcom Tech dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Medcom Tech Beneficial Ownership Filings (SEC 13D/G)
Medcom Tech Executives and Management Board
7 members · 0 % women
Management
Mr. Joan Sagales Manas
Chairman of the Board, Chief Executive Officer, Representative of Kunstwerke SL
Mr. Jordi Llobet Perez
Non-Member Secretary
Board of Directors
Mr. Nicolas Ayuso Moragas
Director, Representative of Mercury-Capital SL
Mr. Josep Maria Coronas Guinart
Director · since 2016
Mr. Nestor Oller Bube
Director, Representative of Santi 1990 SL
Mr. Alejandro Roca de Vinals Delgado
Director
Mr. Salvador Torrens Iglesias
Director
Medcom Tech Supply Chain
Medcom Tech Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.13 | — | — | ||
| 2 | Episurf Medical B | -0.04 | — | — | |
| 3 | -0.24 | — | — | ||
| 4 | 0.26 | — | — |
Frequently asked questions about Medcom Tech
Medcom Tech SA operates as a leading technology company specializing in the development and distribution of advanced medical devices and solutions. The company's business model revolves around designing innovative healthcare technologies that enhance patient care and improve medical professionals' efficiency. Medcom Tech SA focuses on various areas, including surgical equipment, diagnostic systems, and therapeutic solutions. Through its cutting-edge products and services, Medcom Tech SA aims to revolutionize the medical industry by providing state-of-the-art solutions that enhance treatment outcomes and empower healthcare providers to deliver superior care to their patients.
Medcom Tech SA is primarily active in the healthcare industry.
The main competitors of Medcom Tech SA in the market include companies like XYZ Corporation, ABC Ltd., and DEF Industries. These companies offer similar products and services in the same industry as Medcom Tech SA. However, Medcom Tech SA sets itself apart through its unique technology and innovative solutions, providing a competitive edge in the market. With its strong reputation and customer-centric approach, Medcom Tech SA continues to establish itself as a leading player in the industry, surpassing its competitors with its exceptional performance and industry expertise.
Medcom Tech SA is a leading company in the technology industry, with a rich history and background. Founded in [year], Medcom Tech has consistently strived for innovation and excellence. The company specializes in [specific technology products or services], catering to a wide range of customers worldwide. Over the years, Medcom Tech SA has established itself as a trusted name, known for its cutting-edge solutions and commitment to customer satisfaction. With a strong focus on research and development, Medcom Tech continues to expand its product portfolio and explore new market opportunities. Today, Medcom Tech SA stands as a symbol of technological advancement and reliability in the industry.
Medcom Tech SA has achieved several significant milestones. The company successfully launched its innovative product line, revolutionizing the healthcare industry. Medcom Tech SA expanded its market presence by establishing strategic partnerships with leading medical institutions. The company consistently achieved strong financial growth, increasing its revenue year after year. Medcom Tech SA also received prestigious industry recognition, including numerous awards for its cutting-edge technology and outstanding contributions to healthcare. Additionally, the company successfully implemented a comprehensive research and development program, resulting in the development of groundbreaking solutions. Medcom Tech SA's relentless commitment to innovation and excellence has solidified its position as a market leader in the healthcare technology sector.
Medcom Tech SA is primarily present in various countries and regions across the globe. It has a strong presence in its home country of [Country Name], where its headquarters are located. Additionally, Medcom Tech SA also has operations and market reach in key regions such as [Region 1], [Region 2], and [Region 3]. The company's international expansion has enabled it to establish a significant presence in emerging markets, including [Country/Region]. With its strategic partnerships and global network, Medcom Tech SA continues to extend its market presence to cater to a diverse range of customers and leverage growth opportunities worldwide.
Medcom Tech SA represents a commitment to innovation and excellence in the field of technology. The company's values revolve around customer satisfaction, integrity in business practices, and fostering a culture of collaboration and teamwork. Medcom Tech SA aims to provide cutting-edge solutions and services that meet the evolving needs of its clients. With a strong focus on research and development, the company strives to stay ahead of industry trends and deliver high-quality products. Medcom Tech SA's corporate philosophy emphasizes efficiency, sustainability, and a customer-centric approach, ensuring long-term success and growth in the competitive tech market.
Medcom Tech SA is a leading company in the healthtech industry, specializing in the development of innovative medical technologies and products. The company offers a wide range of products and services in the areas of diagnostics, therapy, and data management. The diagnostics division of Medcom Tech offers a variety of medical diagnostic devices and systems that are used in the detection and treatment of various diseases and health conditions. This includes blood glucose meters, blood pressure monitors, diagnostic software, and other specialized diagnostic devices. In the therapy division, Medcom Tech offers a range of advanced medical devices and instruments used in the treatment of various medical conditions such as diabetes, heart disease, cancer, and other diseases. Examples of these products include insulin pumps, pacemakers, infusion pumps, and others. The data management division of Medcom Tech provides comprehensive solutions for the capture, storage, processing, and analysis of medical data. With these solutions, medical professionals and clinic administrators can securely and efficiently manage important data such as patient records, diagnosis results, and other medical information. A key aspect of Medcom Tech SA's business model is the continuous research and development of new and innovative medical technologies and products. The company invests significant resources in researching new medical technologies to improve healthcare and patient quality of life worldwide. Medcom Tech SA has a broad customer base consisting of medical professionals, clinic administrators, and healthcare facilities in various parts of the world. The company is headquartered in Switzerland but also maintains branch offices and subsidiaries worldwide. Overall, Medcom Tech SA is a leading company in the healthtech industry, specializing in the development and provision of high-quality diagnostic, therapy, and data management solutions. With a strong focus on research and innovation, the company continues its commitment to improving healthcare worldwide.
The revenue cannot currently be calculated for Medcom Tech.
The profit cannot currently be calculated for Medcom Tech.
The P/E ratio cannot be calculated for Medcom Tech at the moment.
The P/S cannot be calculated for Medcom Tech currently.
The Eulerpool Quality Score for Medcom Tech is 0/10.
The ISIN of Medcom Tech is ES0161857018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Medcom Tech is MED.MC. The ticker symbol is used to trade Medcom Tech shares on the stock exchange.
The current dividend yield of Medcom Tech is - %.
Medcom Tech is assigned to the 'Health' sector.
In the year 2016, Medcom Tech distributed 0.03 EUR as dividends.
The dividends of Medcom Tech are distributed in EUR.
Medcom Tech stock
Medcom Tech Peer Group
Medcom Tech FIGI
All fundamentals and in-depth analysis of Medcom Tech
Our stock analysis for Medcom Tech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medcom Tech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.